Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2604-2611

  Takahashi, Morio ^a   Ota, Shinichi ^a   Hata, Yasuo ^a   Mikami, Yasuyo ^a   Azuma, Noboru ^b   Nakamura, Toshikazu ^c   Terano, Akira ^d   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Misato Junshin Hospital   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Dokkyo University   (Japan)

Author keywords

gastric fibroblast; gastric ulcer; nonsteroidal antiinflammatory drug; regeneration; restitution

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SCATTER FACTOR;

ARTICLE; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH ULCER;

EID: 0029852719     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119080     Document Type: Article

References (29)

1. Hollander, D. 1994. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: prophylactic and therapeutic strategies. Am. J. Med. 96: 274-281.
2. McCarthy, D.M. 1995. Mechanism of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 30(Suppl. 208):24-29.
3. Robert, A. 1979. Cytoprotection by prostaglandins. Gastroenterology. 77: 761-767.
4. Roth, S., N. Agrawal, M. Mahowald, H. Montoya, D. Robbins, S. Miller, E. Nutting, E. Woods, M. Crager, C. Nissen, and E. Swabb. 1989. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis. Arch. Intern. Med. 149:775-779.
5. Silverstein, F.E., D.Y. Graham, J.R. Senior, H.W. Davies, B.J. Struthers, R.M. Bittman, and G.S. Geis. 1995. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 123:241-249.
6. Walt, R.P. 1992. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N. Engl. J. Med. 327: 1575-1580.
7. Levi, S., R.A. Goodlad, C.Y. Lee, G. Stamp, M.J. Walport, N.A. Wright, and H.J.F. Hodgson. 1990. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 336:840-843.
8. Takahashi, M., S. Ota, A. Terano, K. Yoshiura, M. Matsumura, Y. Niwa, T. Kawabe, T. Nakamura, and M. Omata. 1993. Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture. Biochem. Biophys. Res. Commun. 191:528-534.
9. Takahashi, M., S. Ota, T. Shimada, E. Hamada, T. Kawabe, T. Okudaira, M. Matsumura, N. Kaneko, A. Terano, T. Nakamura, and M. Omata. 1995. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J. Clin. Invest. 95:1994-2003.
10. Watanabe, S., M. Hirose, X.-E. Wang, K. Maehiro, T. Murai, O. Kobayashi, A. Nagahara, and N. Sato. 1994. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem. Biophys. Res. Commun. 199:1453-1460.
11. Takahashi, M., S. Ota, Y. Hata, K. Ogura, M. Kurita, A. Terano, T. Nakamura, and M. Omata. 1996. Constitutive expression of hepatocyte growth factor may maintain the sheet construction of gastric epithelial cells through facilitating actin-myosin contractile system. Biockem. Biophys. Res. Commun. 214:40-46.
12. Matsumoto, K., H. Okazaki, and T. Nakamura. 1992. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 188:235-245.
13. Matsumoto, K., H. Okazaki, and T. Nakamura. 1995. Novel function of prostaglandins as inducer of gene expression of HGF and putative mediators of tissue regeneration. J. Biochem. 117:458-464.
14. Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature (Lond.). 342:440-443.
15. Ota, S., A. Terano, and H. Hiraishi. 1990. A monolayer culture of gastric mucous cells from adult rabbits. Gastroenterol. Jpn. 25:1-7.
16. Regan, J.W., T.J. Bailey, D.J. Pepperl, K.L. Pierce, A.M. Bogardus, J.E. Donello, C.E. Fairbairn, K.M. Kedzie, D.F. Woodward, and D.W. Gil. 1994. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46:213-220.
17. Bastien, L., N. Sawyer, R. Grygorczk, K.M. Metters, and M.A. Adam. 1994. Cloning, functional expression and characterization of the human prostaglandin E2 receptor EP2 subtype. J. Biol. Chem. 269:11873-11877.
18. Pazit, B., L.J. Crofford, R.L. Wilder and T. Hla. 1995. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372:83-87.
19. Katsuyama, M., Y. Sugimoto, T. Namba, A. Irie, M. Negishi, S. Narumiya, and A. Ichikawa. 1994. Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett. 344:74-78.
20. Tashiro, K., M. Hagiya, T. Nishizawa, T. Seki, M. Shimonishi, S. Shimizu, and T. Nakamura. 1990. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA. 87:3200-3204.
21. Coleman, R.A., S.P. Grix, S.A. Head, J.B. Louttit, A. Mallett, and R.L.G. Sheldrick. 1994. A novel inhibitory receptor in piglet saphenous vein. Prostaglandins. 47:151-168.
22. Tsujii, H., Y. Okamoto, E. Kikuchi, M. Matsumoto, and H. Nakano. 1993. Prostaglandin E2 and rat liver regeneration. Gastroenterology. 103:495-499.
23. Katsuyama, M., N. Nishigaki, Y. Sugimoto, K. Morimoto, M. Negishi, S. Narumiya, and A. Ichikawa. 1995. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and Northern blot analysis. FEBS Lett. 372:151-156.
24. Giardiello, F.M., S.R. Hamilton, A.J. Krush, S. Piantadosi, L.M. Hykind, P. Celano, S.V. Booker, C.R. Robinson, and J.A. Offerhaus. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328:1313-1316.
25. Giovannucci, E., E.B. Rimm, M.J. Stampher, G.A. Colditz, A. Ascherio, and W.C. Willet. 1994. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121:241-246.
26. Muscat, J.E., S.E. Stellman, and E.L. Wynder. 1994. Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer (Phila.). 74:1847-1854.
27. Eberhart, C.E., R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1183-1188.
28. Kargman, S., G. O'Neill, P. Vickers, J. Evans, J. Mancini, and S. Jothy. 1995. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:2556-2559.
29. Tsujii, M., and R.N. DuBois. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:493-501.